We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. **nbao Pill ameliorates heart failure via regulating the SGLT1/AMPK/PPARα axis to improve myocardial fatty acid energy metabolism

    Background

    Heart failure (HF) is characterized by a disorder of cardiomyocyte energy metabolism. **nbao Pill (XBW), a traditional Chinese medicine...

    Linjie Pan, Zhanchi Xu, ... Heqing Huang in Chinese Medicine
    Article Open access 11 June 2024
  2. miR-1268a Regulates Fatty Acid Metabolism by Targeting CD36 in Angiotensin II-induced Heart Failure

    Multiple RNAs have been involved in the progress of heart failure. However, the role of miR-1268a in heart failure is still unclear. The...

    Gang Xu, Yi Xu, ... Jun Li in Cell Biochemistry and Biophysics
    Article 15 April 2024
  3. Increased circulating uric acid aggravates heart failure via impaired fatty acid metabolism

    Background

    Increased circulating uric acid (UA) concentration may disrupt cardiac function in heart failure patients, but the specific mechanism...

    Bowen Lou, Haoyu Wu, ... Jianqing She in Journal of Translational Medicine
    Article Open access 16 March 2023
  4. Aldose reductase inhibition alleviates diabetic cardiomyopathy and is associated with a decrease in myocardial fatty acid oxidation

    Background

    Cardiovascular diseases, including diabetic cardiomyopathy, are major causes of death in people with type 2 diabetes. Aldose reductase...

    Keshav Gopal, Qutuba G. Karwi, ... Gary D. Lopaschuk in Cardiovascular Diabetology
    Article Open access 28 March 2023
  5. Fasting increases susceptibility to acute myocardial ischaemia/reperfusion injury through a sirtuin-3 mediated increase in fatty acid oxidation

    Fasting increases susceptibility to acute myocardial ischaemia/reperfusion injury (IRI) but the mechanisms are unknown. Here, we investigate the role...

    Andrew R. Hall, Qutuba G. Karwi, ... Derek J. Hausenloy in Scientific Reports
    Article Open access 29 November 2022
  6. Inhibition of fatty acid uptake by TGR5 prevents diabetic cardiomyopathy

    Diabetic cardiomyopathy is characterized by myocardial lipid accumulation and cardiac dysfunction. Bile acid metabolism is known to play a crucial...

    Hu Wang, Jiaxing Wang, ... Ming Xu in Nature Metabolism
    Article Open access 02 May 2024
  7. Dysregulated palmitic acid metabolism promotes the formation of renal calcium-oxalate stones through ferroptosis induced by polyunsaturated fatty acids/phosphatidic acid

    The pathogenesis of renal calcium-oxalate (CaOx) stones is complex and influenced by various metabolic factors. In parallel, palmitic acid (PA) has...

    Rui Wang, **gdong Zhang, ... Chunyu Liu in Cellular and Molecular Life Sciences
    Article Open access 12 February 2024
  8. Bawei Chenxiang Wan ameliorates right ventricular hypertrophy in rats with high altitude heart disease by SIRT3-HIF1α-PDK/PDH signaling pathway improving fatty acid and glucose metabolism

    Background

    Bawei Chenxiang Wan ( BCW ) is among the most effective and widely used therapies for coronary heart disease and angina pectoris in Tibet....

    Yiwei Han, Shadi Li, ... **aoying Zhang in BMC Complementary Medicine and Therapies
    Article Open access 15 May 2024
  9. MARK4 aggravates cardiac dysfunction in mice with STZ-induced diabetic cardiomyopathy by regulating ACSL4-mediated myocardial lipid metabolism

    Diabetic cardiomyopathy is a specific type of cardiomyopathy. In DCM, glucose uptake and utilization are impaired due to insulin deficiency or...

    Yi Wu, **gqi Zhang, ... Lu Fu in Scientific Reports
    Article Open access 05 June 2024
  10. 4-phenylbutyric acid improves sepsis-induced cardiac dysfunction by modulating amino acid metabolism and lipid metabolism via Comt/Ptgs2/Ppara

    Introduction

    Cardiac dysfunction after sepsis the most common and severe sepsis-related organ failure. The severity of cardiac damage in sepsis...

    Yuanqun Zhou, Yu Zhu, ... Tao Li in Metabolomics
    Article Open access 19 April 2024
  11. Myocardial Metabolism in Heart Failure

    Purpose of Review

    Myocardial metabolism is intricately linked to cardiac function. Perturbations of cardiac energy metabolism result in an...

    Sher May Ng, Stefan Neubauer, Oliver J Rider in Current Heart Failure Reports
    Article Open access 17 February 2023
  12. Altered acylcarnitine metabolism and inflexible mitochondrial fuel utilization characterize the loss of neonatal myocardial regeneration capacity

    Myocardial regeneration capacity declines during the first week after birth, and this decline is linked to adaptation to oxidative metabolism....

    E. Kankuri, P. Finckenberg, ... E. Mervaala in Experimental & Molecular Medicine
    Article Open access 03 April 2023
  13. Pharmacological Effects of Botanical Drugs on Myocardial Metabolism in Chronic Heart Failure

    Although there have been significant advances in the treatment of heart failure in recent years, chronic heart failure remains a leading cause of...

    Yu-xuan Hu, Sheng-lei Qiu, ... **ao-lei Lai in Chinese Journal of Integrative Medicine
    Article 26 September 2023
  14. Dual roles of myocardial mitochondrial AKT on diabetic cardiomyopathy and whole body metabolism

    Background

    The PI3K/AKT pathway transduces the majority of the metabolic actions of insulin. In addition to cytosolic targets, insulin-stimulated...

    Yu-Han Chen, Albert P. Ta, ... ** H. Wang in Cardiovascular Diabetology
    Article Open access 27 October 2023
  15. Targeting Myocardial Substrate Metabolism in the Failing Heart: Ready for Prime Time?

    Purpose of Review

    We review the clinical benefits of altering myocardial substrate metabolism in heart failure.

    Recent Findings

    Modulation of cardiac...

    Salva R. Yurista, Shi Chen, ... Christopher T. Nguyen in Current Heart Failure Reports
    Article 14 May 2022
  16. The abnormalities of free fatty acid metabolism in patients with hypertrophic cardiomyopathy, a single-center retrospective observational study

    Background

    Previous studies have shown the importance of energy deficiency and malfunctioning mitochondria in the pathophysiology of hypertrophic...

    Ke Zhang, Zhongyu Yuan, ... Yongqiang Lai in BMC Cardiovascular Disorders
    Article Open access 20 June 2024
  17. Pancreatic fatty replacement as risk marker for altered glucose metabolism and cardiac iron and complications in thalassemia major

    Objectives

    This multicenter study assessed the extent of pancreatic fatty replacement and its correlation with demographics, iron overload, glucose...

    Antonella Meloni, Mario Nobile, ... Alessia Pepe in European Radiology
    Article Open access 28 April 2023
  18. Serum metabolism characteristics of patients with myocardial injury after noncardiac surgery explored by the untargeted metabolomics approach

    Background

    Myocardial injury after noncardiac surgery (MINS) is one of the most common complications associated with postoperative adverse...

    Yuanjia Zhang, Mengjia Kou, ... Xu Zhao in BMC Cardiovascular Disorders
    Article Open access 03 February 2024
  19. Targeting fatty acid metabolism for fibrotic disorders

    Fibrosis is defined by abnormal accumulation of extracellular matrix, which can affect virtually every organ system under diseased conditions....

    Seonghwan Hwang, Ki Wung Chung in Archives of Pharmacal Research
    Article 18 October 2021
Did you find what you were looking for? Share feedback.